Annual D&A
$2.78M$675.00K+32.13%
Summary
- Current Value
- As of today, RNA annual D&A is $2.78M, up +32.13% on
- Historical Performance
- RNA annual D&A is up +334.43% over the past 3 years, and up +697.70% over the past 5 years
- All-Time High Comparison
- RNA annual D&A is currently at its all-time high
- 3-Year Low Comparison
- RNA annual D&A is +100.14% above its 3-year low of $1.39M reached on an earlier date
- Sector Comparison
- RNA annual D&A is higher than 55.53% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $2.78M | +32.1% | +334.4% | +697.7% | +624.8% | |
| Quarterly D&A | $1.06M | +48.7% | +185.4% | +945.5% | +585.7% | |
| TTM D&A | $3.39M | +580.0% | +179.5% | +475.1% | +2103.3% | |
| Price | $72.37 | +135.0% | +264.9% | +185.8% | – | |
| Annual SG&A | $86.24M | +59.1% | +229.2% | +1587.0% | +3433.0% | |
| Annual Total Expenses | $389.83M | +59.0% | +206.1% | +1883.8% | +3484.0% | |
| Annual Operating Expenses | $389.83M | +59.0% | +206.1% | +1883.8% | +3484.0% | |
| Annual Revenue | $10.90M | +14.0% | +16.9% | +369.9% | +2775.2% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.78M | at high | |
| 5Y | $2.78M | at high | |
| All | $2.78M | at high |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.39M | N/A | +100.1% |
| 5Y | $373.00K | N/A | +644.2% |
| All | $348.00K | +697.7% |
Depreciation & Amortization History
| Year | Value | Change |
|---|---|---|
| $2.78M | +32.1% | |
| $2.10M | +51.5% | |
| $1.39M | +117.1% | |
| $639.00K | +71.3% |
| Year | Value | Change |
|---|---|---|
| $373.00K | +7.2% | |
| $348.00K | -9.1% | |
| $383.00K | - |
FAQ
What is the current annual D&A of RNA?
As of today, RNA annual D&A is $2.78M
What is 1-year change in RNA annual D&A?
RNA annual D&A is up +32.13% year-over-year
What is 3-year change in RNA annual D&A?
RNA annual D&A is up +334.43% over the past 3 years
How far is RNA annual D&A from its all-time high?
RNA annual D&A is currently at its all-time high
How does RNA annual D&A rank versus sector peers?
RNA annual D&A is higher than 55.53% of companies in Healthcare sector
When is RNA next annual earnings release?
The next annual earnings release for RNA is on
Quarterly D&A
$1.06M$242.00K+29.73%
Summary
- Current Value
- As of today, RNA quarterly D&A is $1.06M, up +29.73% on
- Historical Performance
- RNA quarterly D&A is up +48.73% year-over-year, and up +185.41% over the past 3 years
- All-Time High Comparison
- RNA quarterly D&A is currently -18.77% below its historical high of $1.30M set on
- 3-Year Low Comparison
- RNA quarterly D&A is +168.62% above its 3-year low of -$1.54M reached on
- Sector Comparison
- RNA quarterly D&A is higher than 59.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $1.06M | +29.7% | +48.7% | +185.4% | +945.5% | |
| Annual D&A | $2.78M | – | +32.1% | +334.4% | +697.7% | |
| TTM D&A | $3.39M | +11.4% | +580.0% | +179.5% | +475.1% | |
| Price | $72.37 | +54.1% | +135.0% | +264.9% | +185.8% | |
| Quarterly SG&A | $46.33M | +25.7% | +99.1% | +359.0% | +1133.2% | |
| Quarterly Total Expenses | $186.92M | +16.0% | +125.9% | +305.6% | +1317.7% | |
| Quarterly Operating Expenses | $200.23M | +15.0% | +100.7% | +325.9% | +1646.3% | |
| Quarterly Revenue | $12.48M | +224.3% | +434.0% | +402.6% | +614.5% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.06M | at high | |
| 3Y | $1.30M | -18.8% | |
| 5Y | $1.30M | -18.8% | |
| All | $1.30M | -18.8% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $738.00K | N/A | +43.1% |
| 3Y | -$1.54M | +168.6% | |
| 5Y | -$1.54M | +168.6% | |
| All | -$1.54M | +168.6% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of RNA?
As of today, RNA quarterly D&A is $1.06M
What is RNA quarterly D&A most recent change?
RNA quarterly D&A was up +29.73% on September 30, 2025
What is 1-year change in RNA quarterly D&A?
RNA quarterly D&A is up +48.73% year-over-year
How far is RNA quarterly D&A from its all-time high?
RNA quarterly D&A is currently -18.77% below its historical high of $1.30M set on September 30, 2023
How does RNA quarterly D&A rank versus sector peers?
RNA quarterly D&A is higher than 59.73% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
TTM D&A
$3.39M$346.00K+11.36%
Summary
- Current Value
- As of today, RNA TTM D&A is $3.39M, up +11.36% on
- Historical Performance
- RNA TTM D&A is up +579.96% year-over-year, and up +179.49% over the past 3 years
- All-Time High Comparison
- RNA TTM D&A is currently -15.62% below its historical high of $4.02M set on
- 3-Year Low Comparison
- RNA TTM D&A is +579.96% above its 3-year low of $499.00K reached on
- Sector Comparison
- RNA TTM D&A is higher than 56.42% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $3.39M | +11.4% | +580.0% | +179.5% | +475.1% | |
| Annual D&A | $2.78M | – | +32.1% | +334.4% | +697.7% | |
| Quarterly D&A | $1.06M | +29.7% | +48.7% | +185.4% | +945.5% | |
| Price | $72.37 | +54.1% | +135.0% | +264.9% | +185.8% | |
| TTM SG&A | -$4.41B | -3711.4% | -6055.9% | -10000.0% | -10000.0% | |
| TTM Revenue | $20.87M | +94.5% | +106.3% | +151.2% | +242.7% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.39M | at high | |
| 3Y | $4.02M | -15.6% | |
| 5Y | $4.02M | -15.6% | |
| All | $4.02M | -15.6% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.78M | N/A | +22.2% |
| 3Y | $499.00K | +580.0% | |
| 5Y | $341.00K | +895.0% | |
| All | $154.00K | +2103.3% |
TTM D&A History
FAQ
What is the current TTM D&A of RNA?
As of today, RNA TTM D&A is $3.39M
What is RNA TTM D&A most recent change?
RNA TTM D&A was up +11.36% on September 30, 2025
What is 1-year change in RNA TTM D&A?
RNA TTM D&A is up +579.96% year-over-year
How far is RNA TTM D&A from its all-time high?
RNA TTM D&A is currently -15.62% below its historical high of $4.02M set on September 30, 2023
How does RNA TTM D&A rank versus sector peers?
RNA TTM D&A is higher than 56.42% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
Data Sources & References
- RNA Official Website www.aviditybiosciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1599901/000159990125000210/0001599901-25-000210-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990125000059/0001599901-25-000059-index.htm
- RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
- RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna